https://www.selleckchem.com/pr....oducts/bms-986165.ht
ty and primary graft dysfunction grade 3 at 72 hours did not differ significantly between groups. EVLP offers the potential to increase lung donor utilization while providing similar short-term outcomes and mid- to long-term survival. 2020 Annals of Cardiothoracic Surgery. All rights reserved.Tricuspid regurgitation (TR) is a common valvular heart disease affecting 1.6 million people in the United States (US) and 70 million people worldwide. The age- and sex-adjusted prevalence of more than or equal to moderate TR in the US i
Like
Comment
Share
